ArticleJournal for immunotherapy of cancer2026
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.
Anmbreen Jamroze et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.